Please try another search
For the fiscal year ended 31 March 2018, Camson Bio Technologies Ltd revenues increased 25% to RS193.1M. Net loss applicable to common stockholders decreased 52% to RS143.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other Expenses decrease of 59% to RS65.3M (expense), Financial costs - Balancing value decrease of 70% to RS7.3M (expense).
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Revenue | 461.68 | 635.12 | 470.96 | 462.44 |
Gross Profit | 163.57 | 299.55 | 300.2 | 200.17 |
Operating Income | -84.71 | 40.16 | 13.51 | 38.64 |
Net Income | -40.55 | 17.51 | 2.33 | 40.07 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Assets | 3494.9 | 3157.85 | ||
Total Liabilities | 862.44 | 545.12 | ||
Total Equity | 2632.46 | 2612.73 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review